Yi J, Wang Z W, Cang H, Chen Y Y, Zhao R, Yu B M, Tang X M
Department of Cell Biology, Shanghai Second Medical University, 280 Chongqing South Road, Shanghai 200025, China.
World J Gastroenterol. 2001 Oct;7(5):722-5. doi: 10.3748/wjg.v7.i5.722.
To explore the association of methylation of the CpG island in the promotor of the p16 tumor suppressor gene with the clinicopathological characteristics of the colorectal cancers.
Methylation-specific PCR (MSP) was used to detect p16 methylation of 62 sporadic colorectal cancer specimens.
p16 methylation was detected in 42% of the tumors.Dukes'staging was associated with p16 methylation status.p16 methylation occurred more frequently in Dukes'C and D patients (75.9%) than in Dukes'A and B patients (12.1%).
p16 methylation plays a role in the carcinogenesis of a subset of colorectal cancer, and it might be linked to poor prognosis.
探讨p16肿瘤抑制基因启动子区CpG岛甲基化与结直肠癌临床病理特征的相关性。
采用甲基化特异性PCR(MSP)检测62例散发性结直肠癌标本的p16甲基化情况。
42%的肿瘤检测到p16甲基化。Dukes分期与p16甲基化状态相关。p16甲基化在Dukes' C期和D期患者中(75.9%)比在Dukes' A期和B期患者中(12.1%)更常见。
p16甲基化在一部分结直肠癌的致癌过程中起作用,并且可能与预后不良有关。